目的 分析厦门大学附属中山医院使用阿伐曲泊帕片患者的病例特点和用药情况。方法 回顾性分析2021年7月—2022年12月厦门大学附属中山医院使用阿伐曲泊帕片患者的病例资料，记录患者基本信息、疾病、用药情况，对阿伐曲泊帕片的用药情况进行汇总和合理性评价。结果 共抽取134份阿伐曲泊帕片用药病例，用药排名前3位的科室是血液科、肝胆外科、重症医学科。134份病例中合理120份，不合理14份，不合理类型主要包括适应证不合理、用法用量不合理、用药疗程不合理。结论 阿伐曲泊帕片在厦门大学附属中山医院临床应用还有待进一步的规范和探讨。

Objective To analyze the case characteristics and medication situation of patients using Avatrombopag Tablets in Zhongshan Hospital Affiliated to Xiamen University. Methods The case data of patients using Avatrombopag Tablets in Zhongshan Hospital Affiliated to Xiamen University from July 2021 to December 2022 were retrospectively analyzed, the basic information, disease and drug use of patients were recorded, and the drug use of Avatrombopag Tablets was summarized and rational evaluation was made. Results A total of 134 cases of Avatrombopag Tablets were selected, and the top three departments were hematology, hepatobiliary surgery, and intensive care medicine. Among the 134 cases, 120 cases were reasonable, while 14 cases were unreasonable, including unreasonable indications, inappropriate usage and dosage, and inappropriate medication course. Conclusion The clinical application of Avatrombopag Tablets in Zhongshan Hospital Affiliated to Xiamen University still needs to be further standardized and discussed.

R973